Cabot (CBT) Projected to Release Earnings on Monday

Cabot (NYSE:CBT) is anticipated to post its Q4 2026 results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $1.55 per share and revenue of $927.29 million for the quarter. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Individuals are encouraged to explore the company’s upcoming Q4 2026 earnings report for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%. Cabot’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.90 earnings per share. On average, analysts expect Cabot to post $6.35 EPS for the current fiscal year and $7.08 EPS for the next fiscal year.

Cabot Stock Up 1.0%

Shares of Cabot stock opened at $74.57 on Friday. The stock has a 50-day moving average price of $77.98 and a 200 day moving average price of $79.50. The company has a market cap of $3.85 billion, a P/E ratio of 21.01, a P/E/G ratio of 8.69 and a beta of 0.83. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot has a 1 year low of $58.33 and a 1 year high of $94.53.

Insider Transactions at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 229,597 shares of company stock worth $19,646,746 in the last three months. 3.08% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have weighed in on CBT. Truist Financial set a $100.00 target price on Cabot in a research note on Wednesday, August 5th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. UBS Group decreased their price target on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday, October 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $87.80.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.